{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2F51142c5a-0c09-420d-8936-e0f3b697b230","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/51142c5a-0c09-420d-8936-e0f3b697b230\"></iframe>","title":"Advances in Diffuse Large B-Cell Lymphoma with Dr Gilles Salles","description":"\n        <p>Dr Gilles Salles from Memorial Sloan Kettering Cancer Center in New York City discusses recent data from clinical trials evaluating targeted therapies for diffuse large B-cell lymphoma.</p>\n\n<p>CME information and select publications <a href=\"http://www.researchtopractice.com/OncologyTodayDLBCL22\" rel=\"nofollow\">here</a>.</p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/cd7f0180-fd07-4881-b8ed-215cf7da1380/cover.jpg"}